首页> 美国卫生研究院文献>Cardiology Research >Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients
【2h】

Effects of Holding Beta-Blockers on the Vital Signs of Heart Failure Patients

机译:保持β阻滞剂对心力衰竭患者生命迹象的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Heart failure with reduced ejection fraction (HFrEF) is associated with recurrent hospitalizations and high mortality. Guideline-directed medical therapy (GDMT) reduces morbidity, mortality and re-admission rates. Despite the evidence, less than 50% of patients with HFrEF are prescribed appropriate medical therapy. When hospitalized patients have these medications discontinued on admission or during hospitalization, they are less likely to have them restarted on discharge. The goal of this study was to determine the incidence of disruption of beta-blocker (BB) therapy during hospitalization for HFrEF patients admitted to an academic tertiary referral hospital.
机译:射血分数减少(HFREF)的心力衰竭与复发住院和高死亡率有关。指导指导的医疗治疗(GDMT)降低了发病率,死亡率和重新入学率。尽管证据证据,但少于50%的HFREF患者进行了适当的医疗疗法。当住院患者在入院或住院期间停止这些药物时,它们不太可能在出院时重新开始。本研究的目的是确定入院期间患有学术高等教育医院的HFREF患者的β阻滞剂(BB)疗法的破坏发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号